MedTrace Logo

Evaluation of the Bifurcated Multilayer Flow Modulator for the Treatment of Abdominal Aortic Aneurysm

NCT03024554 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2026-08-10

Study results available
· View outcomes & findings →

Summary

The study purpose is to determine the safety and efficacy of the BMFM used for the endovascular treatment of aortic aneurysm involving iliac arteries. The BMFM is an adaptation of the aortic MFM® to the aorto-iliac bifurcation anatomy. It should be noted that the aortic MFM® has CE mark approval for the aortic aneurysm treatment.

Conditions

  • Aortic Aneurysm, Abdominal
  • Aortic Aneurysm, Thoracoabdominal

Interventions

DEVICE

Implantation of the Bifurcated Multilayer Flow Modulator

Sponsors & Collaborators

  • Cardiatis

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-04-11
Primary Completion
2018-08-07
Completion
2023-12-07

Countries

  • Belgium
  • Bulgaria
  • Morocco
  • Romania
  • Slovenia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03024554 on ClinicalTrials.gov